skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: Wiley-Blackwell Open Access Collection remover nível superior: Revistas revisadas por pares remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Comparison of the toxicity profile of PD‐1 versus PD‐L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature
Comparison of the toxicity profile of PD‐1 versus PD‐L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of the toxicity profile of PD‐1 versus PD‐L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature

Pillai, Rathi N. ; Behera, Madhusmita ; Owonikoko, Taofeek K. ; Kamphorst, Alice O. ; Pakkala, Suchita ; Belani, Chandra P. ; Khuri, Fadlo R. ; Ahmed, Rafi ; Ramalingam, Suresh S.

Cancer, 2018-01, Vol.124 (2), p.271-277 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
2
Radiofrequency ablation of stage IA non–small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial
Radiofrequency ablation of stage IA non–small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Radiofrequency ablation of stage IA non–small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial

Dupuy, Damian E. ; Fernando, Hiran C. ; Hillman, Shauna ; Ng, Thomas ; Tan, Angelina D. ; Sharma, Amita ; Rilling, William S. ; Hong, Kelvin ; Putnam, Joe B.

Cancer, 2015-10, Vol.121 (19), p.3491-3498 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer

Pruis, Melinda A ; Krebs, Matthew G ; Plummer, Ruth ; De Vos, Filip ; Angevin, Eric ; Prenen, Hans ; Forster, Martin D ; Clack, Glen ; Van der Aa, Annegret ; Tjwa, Marc ; Jansen, Ellen ; Perera, Timothy ; Lolkema, Martijn P

2023-12

Texto completo disponível

Citações Citado por
4
MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells
MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells

Stutvoet, Thijs S ; Kol, Arjan ; Vries, Elisabeth GE ; Bruyn, Marco ; Fehrmann, Rudolf SN ; Terwisscha van Scheltinga, Anton GT ; Jong, Steven

The Journal of pathology, 2019-09, Vol.249 (1), p.52-64 [Periódico revisado por pares]

Chichester, UK: John Wiley & Sons, Ltd

Texto completo disponível

Citações Citado por
5
EML4‐ALK fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non‐small cell lung cancer
EML4‐ALK fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non‐small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

EML4‐ALK fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non‐small cell lung cancer

Christopoulos, Petros ; Endris, Volker ; Bozorgmehr, Farastuk ; Elsayed, Mei ; Kirchner, Martina ; Ristau, Jonas ; Buchhalter, Ivo ; Penzel, Roland ; Herth, Felix J. ; Heussel, Claus P. ; Eichhorn, Martin ; Muley, Thomas ; Meister, Michael ; Fischer, Jürgen R. ; Rieken, Stefan ; Warth, Arne ; Bischoff, Helge ; Schirmacher, Peter ; Stenzinger, Albrecht ; Thomas, Michael

International journal of cancer, 2018-06, Vol.142 (12), p.2589-2598 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
6
Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma
Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma

Christopoulos, P. ; Kirchner, M. ; Bozorgmehr, F. ; Endris, V. ; Elsayed, M. ; Budczies, J. ; Ristau, J. ; Penzel, R. ; Herth, F.J. ; Heussel, C.P. ; Eichhorn, M. ; Muley, T. ; Meister, M. ; Fischer, J.R. ; Rieken, S. ; Lasitschka, F. ; Bischoff, H. ; Sotillo, R. ; Schirmacher, P. ; Thomas, M. ; Stenzinger, A.

International journal of cancer, 2019-01, Vol.144 (1), p.190-199 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
7
Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy
Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy

Cheng, Yuan ; Zhang, Tao ; Xu, Qing

MedComm (2020), 2021-12, Vol.2 (4), p.692-729 [Periódico revisado por pares]

China: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
8
The association between proton pump inhibitor use and systemic anti‐tumour therapy on survival outcomes in patients with advanced non‐small cell lung cancer: A systematic review and meta‐analysis
The association between proton pump inhibitor use and systemic anti‐tumour therapy on survival outcomes in patients with advanced non‐small cell lung cancer: A systematic review and meta‐analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

The association between proton pump inhibitor use and systemic anti‐tumour therapy on survival outcomes in patients with advanced non‐small cell lung cancer: A systematic review and meta‐analysis

Wei, Na ; Zheng, Bin ; Que, Wancai ; Zhang, Jin ; Liu, Maobai

British journal of clinical pharmacology, 2022-07, Vol.88 (7), p.3052-3063 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
9
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer

Mitsudomi, Tetsuya ; Yatabe, Yasushi

The FEBS journal, 2010, Vol.277 (2), p.301-308 [Periódico revisado por pares]

Oxford, UK: Oxford, UK : Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
10
Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non‐Small Cell Lung Cancer
Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non‐Small Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non‐Small Cell Lung Cancer

Chae, Young Kwang ; Davis, Andrew A. ; Agte, Sarita ; Pan, Alan ; Simon, Nicholas I. ; Iams, Wade T. ; Cruz, Marcelo R. ; Tamragouri, Keerthi ; Rhee, Kyunghoon ; Mohindra, Nisha ; Villaflor, Victoria ; Park, Wungki ; Lopes, Gilberto ; Giles, Francis J.

The oncologist (Dayton, Ohio), 2019-06, Vol.24 (6), p.820-828 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2001  (19)
  2. 2001Até2006  (41)
  3. 2007Até2012  (75)
  4. 2013Até2019  (228)
  5. Após 2019  (459)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.